{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:08:05Z","timestamp":1789866485829,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.tibtech.2014.06.006","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T20:33:51Z","timestamp":1405024431000},"page":"400-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["The case for transmissible antivirals to control population-wide infectious disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Timothy","family":"Notton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Sardany\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel D.","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leor S.","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2014.06.006_bib0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/oxfordjournals.epirev.a036121","article-title":"Herd immunity: history, theory, practice","volume":"15","author":"Fine","year":"1993","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0010","first-page":"27","article-title":"Vaccination coverage among children enrolled in Head Start programs or day care facilities or entering school","volume":"49","author":"Jiles","year":"2000","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0749-3797(01)00274-4","article-title":"National, state and urban-area vaccination-coverage levels among children aged 19-35 months, United States, 1999","volume":"20","author":"Luman","year":"2001","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0020","series-title":"Gonorrhea Transmission Dynamics and Control","author":"Hethcote","year":"1984"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0025","series-title":"Infectious Diseases of Humans: Dynamics and Control","author":"Anderson","year":"1991"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1073\/pnas.94.1.338","article-title":"Heterogeneities in the transmission of infectious agents: implications for the design of control programs","volume":"94","author":"Woolhouse","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature04153","article-title":"Superspreading and the effect of individual variation on disease emergence","volume":"438","author":"Lloyd-Smith","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0040","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/j.gastro.2009.02.006","article-title":"Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men","volume":"136","author":"van de Laar","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature03072","article-title":"Host immunity and synchronized epidemics of syphilis across the United States","volume":"433","author":"Grassly","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0050","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/00002030-199409000-00018","article-title":"Mapping a social network of heterosexuals at high risk for HIV infection","volume":"8","author":"Woodhouse","year":"1994","journal-title":"AIDS"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/326137a0","article-title":"Transmission dynamics of HIV infection","volume":"326","author":"May","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.epidem.2012.04.002","article-title":"Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia","volume":"4","author":"Graw","year":"2012","journal-title":"Epidemics"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00126334-200502010-00012","article-title":"The appropriateness of core group interventions using presumptive periodic treatment among rural Zimbabwean women who exchange sex for gifts or money","volume":"38","author":"Cowan","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0070","first-page":"32","article-title":"Understanding culture and HIV\/AIDS in sub-Saharan Africa","volume":"10","author":"Sovran","year":"2013","journal-title":"SAHARA J."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1728-4465.2007.00127.x","article-title":"Ties of dependence: AIDS and transactional sex in rural Malawi","volume":"38","author":"Swidler","year":"2007","journal-title":"Stud. Fam. Plann."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0080","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2105\/AJPH.86.12.1709","article-title":"The cost-effectiveness of HIV prevention targeting: how much more bang for the buck?","volume":"86","author":"Kahn","year":"1996","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","article-title":"Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model","volume":"373","author":"Granich","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0090","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0140-6736(06)69162-9","article-title":"The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic","volume":"368","author":"Montaner","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0095","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0030124","article-title":"Modelling the impact of antiretroviral use in resource-poor settings","volume":"3","author":"Baggaley","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(08)61698-0","article-title":"Treating our way out of the HIV pandemic: could we, would we, should we?","volume":"373","author":"Garnett","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0105","doi-asserted-by":"crossref","first-page":"e1002015","DOI":"10.1371\/journal.pcbi.1002015","article-title":"Autonomous targeting of infectious superspreaders using engineered transmissible therapies","volume":"7","author":"Metzger","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-7622-2-9","article-title":"The epidemiological impact of antiretroviral use predicted by mathematical models: a review","volume":"2","author":"Baggaley","year":"2005","journal-title":"Emerg. Themes Epidemiol."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0115","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/JVI.02741-12","article-title":"Design requirements for interfering particles to maintain coadaptive stability with HIV-1","volume":"87","author":"Rouzine","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0120","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1128\/JVI.00932-13","article-title":"Reply to \u2018Coadaptive Stability of Interfering Particles with HIV-1 When There Is an Evolutionary Conflict\u2019","volume":"87","author":"Rouzine","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0125","doi-asserted-by":"crossref","first-page":"10028","DOI":"10.1128\/JVI.77.18.10028-10036.2003","article-title":"Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection","volume":"77","author":"Weinberger","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/226325a0","article-title":"Defective viral particles and viral disease processes","volume":"226","author":"Huang","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0135","series-title":"Fields Virology","first-page":"77","article-title":"Generation and replication of defective viral genomes","author":"Holland","year":"1990"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1126\/science.1115030","article-title":"Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes","volume":"311","author":"Aaskov","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0145","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.0608138103","article-title":"Gene transfer in humans using a conditionally replicating lentiviral vector","volume":"103","author":"Levine","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0150","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood-2012-07-447250","article-title":"Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV","volume":"121","author":"Tebas","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0155","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1089\/hum.2005.16.1463","article-title":"Characterization of human immunodeficiency virus (HIV)-2 vector mobilization by HIV-1","volume":"16","author":"Morris","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00002030-200102160-00010","article-title":"Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection","volume":"15","author":"Dukers","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0165","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.287.5453.650","article-title":"A tale of two futures: HIV and antiretroviral therapy in San Francisco","volume":"287","author":"Blower","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0170","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a009924","article-title":"Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative","volume":"150","author":"Fine","year":"1999","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0175","doi-asserted-by":"crossref","first-page":"e1003193","DOI":"10.1371\/journal.ppat.1003193","article-title":"Phylodynamic analysis of the emergence and epidemiological impact of transmissible defective dengue viruses","volume":"9","author":"Ke","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0180","doi-asserted-by":"crossref","first-page":"e19447","DOI":"10.1371\/journal.pone.0019447","article-title":"Defective interfering viral particles in acute dengue infections","volume":"6","author":"Li","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jtbi.2004.09.009","article-title":"The effect of treatment on pathogen virulence","volume":"233","author":"Porco","year":"2005","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1098\/rspb.1994.0012","article-title":"Superinfection and the evolution of parasite virulence","volume":"255","author":"Nowak","year":"1994","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0195","doi-asserted-by":"crossref","first-page":"1243727","DOI":"10.1126\/science.1243727","article-title":"Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective","volume":"343","author":"Fraser","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0200","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/hum.2012.229","article-title":"Biosafety features of lentiviral vectors","volume":"24","author":"Schambach","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0205","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/mt.2009.179","article-title":"Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors","volume":"17","author":"Modlich","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jgm.2691","article-title":"Patient monitoring and follow-up in lentiviral clinical trials","volume":"15","author":"McGarrity","year":"2013","journal-title":"J. Gene Med."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0215","doi-asserted-by":"crossref","first-page":"132ra153","DOI":"10.1126\/scitranslmed.3003761","article-title":"Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells","volume":"4","author":"Scholler","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0220","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/sj.mt.6300297","article-title":"New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy","volume":"15","author":"Pike-Overzet","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0225","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.270.5235.470","article-title":"Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients","volume":"270","author":"Bordignon","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0230","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood-2011-08-373738","article-title":"How I treat HIV-associated lymphoma","volume":"119","author":"Dunleavy","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0235","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymthe.2003.11.003","article-title":"In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication","volume":"9","author":"Davis","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0240","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/mt.2009.316","article-title":"HIV sequence variation associated with env antisense adoptive T-cell therapy in the hNSG mouse model","volume":"18","author":"Mukherjee","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0245","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1128\/JVI.72.4.2663-2670.1998","article-title":"A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences","volume":"72","author":"Chong","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.tibtech.2014.06.006_bib0250","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott\u2013Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0255","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.tibtech.2014.06.006_bib0260","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N. Engl. J. Med."}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779914001292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779914001292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T05:25:05Z","timestamp":1598073905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779914001292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0167779914001292"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2014.06.006","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The case for transmissible antivirals to control population-wide infectious disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tibtech.2014.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}